Hero Image

Leading 5 Prostate Cancer Treatments: Benefits & Access

Prostate cancer treatments have advanced dramatically, giving men more effective options with fewer side effects.

In this guide, you’ll learn about five leading treatments, the benefits of each, how to choose what’s right for you, and where to access expert care—plus practical tips to help you feel confident in your next steps.

Always discuss choices with your care team; the best plan depends on your cancer’s risk group, overall health, and personal goals. For deeper reading, see patient-friendly overviews from the American Cancer Society and the National Cancer Institute (NCI).

5 leading prostate cancer treatments

These options are commonly recommended and can be used alone or in combination, depending on stage, PSA, Gleason grade group, and imaging findings. For guideline context, see the NCCN Patient Guidelines and the EAU patient resources.

  1. Active surveillance (AS) – Closely monitors low-risk prostate cancer with regular PSA tests, MRIs, and biopsies, delaying treatment unless the cancer shows signs of growth.
    • Benefits: Avoids or postpones side effects from surgery or radiation; preserves quality of life.
    • Best for: Very-low and low-risk cancers; some favorable intermediate-risk cases.
    • Considerations: Requires reliable follow-up; some men find the monitoring anxiety-provoking. Learn more via NICE guidance.
  2. Radical prostatectomy (surgery) – Removes the prostate and nearby tissues; can be open, laparoscopic, or robot-assisted.
    • Benefits: Provides precise pathology; rapidly lowers PSA; strong option for localized disease in healthy candidates.
    • Best for: Localized or locally advanced disease in men fit for surgery.
    • Considerations: Risks include urinary incontinence and erectile dysfunction; outcomes vary by surgeon experience. See the AUA patient page.
  3. External beam radiation therapy (EBRT) – Targets the prostate from outside the body (e.g., IMRT/IGRT, SBRT, proton therapy) over days to weeks.
    • Benefits: Noninvasive; similar cure rates to surgery for many risk groups; SBRT offers convenient short courses.
    • Best for: Localized or locally advanced disease; an alternative to surgery or used after surgery if needed.
    • Considerations: Temporary bowel/bladder irritation; sexual side effects may appear later; proton therapy is an option in some centers (learn about proton therapy). Patient-friendly info at RTAnswers (ASTRO).
  4. Brachytherapy (internal radiation) – Places radioactive seeds or temporary catheters inside the prostate to deliver radiation from within.
    • Benefits: Highly targeted; can be a one-time procedure (low-dose seeds) or short course (high-dose-rate); often combined with EBRT for higher-risk disease.
    • Best for: Localized disease; as monotherapy for low–intermediate risk or with EBRT for higher risk.
    • Considerations: Urinary irritation/obstruction can occur; not ideal if the prostate is very large without prior downsizing. See the American Brachytherapy Society.
  5. Systemic therapies – Treat cancer throughout the body; include androgen deprivation therapy (ADT), next-generation hormone blockers, chemotherapy, targeted therapy, immunotherapy, and radioligand therapy.
    • Benefits: Essential for advanced or metastatic disease; often combined with local therapy in high-risk cases.
    • Examples: ADT; androgen receptor inhibitors; chemotherapy (docetaxel); targeted therapy (PARP inhibitors for some DNA-repair mutations); immunotherapy (learn about immunotherapy); PSMA-targeted radioligand therapy (FDA info).
    • Considerations: Side effects vary and can include hot flashes, fatigue, metabolic changes, low blood counts; genetic testing may guide targeted options.

How to choose the right treatment

Your “best” option balances cure rate, side effects, convenience, and personal values.

Use these steps with your care team to narrow choices confidently.

1) Know your risk group

  • Risk stratification (low, intermediate, high) comes from PSA, Gleason grade group, clinical stage, and imaging. See the NCI overview of PSA testing.
  • Multiparametric MRI and, in some cases, PSMA PET help refine staging and treatment planning.

2) Map your priorities

  • If avoiding surgery is a priority, EBRT or brachytherapy may fit better.
  • If you want a one-time local therapy, consider brachytherapy or SBRT where appropriate.
  • If pathology detail matters to you, surgery provides definitive tissue analysis.

3) Get the right tests

  • Confirm biopsy grade with expert pathology when possible.
  • Discuss genomic classifiers and germline testing; targeted therapies may be options for men with DNA-repair mutations. Start with the NCI’s patient treatment overview.

4) Seek expert opinions

  • Meet both a urologic surgeon and a radiation oncologist to understand trade-offs.
  • Second opinions at academic or high-volume centers can clarify complex decisions. The NCCN Patient Guidelines can help you prepare questions.

5) Consider clinical trials

  • Trials can offer cutting-edge options and may be available for every stage—from active surveillance enhancements to advanced systemic therapies. Search ClinicalTrials.gov.

Where to access these treatments

  • NCI-Designated Cancer Centers: Multidisciplinary teams with access to trials and advanced imaging; find centers via the NCI locator.
  • Academic medical centers: Often offer robotic surgery, SBRT, brachytherapy, and PSMA PET/radioligand therapy programs.
  • Community cancer programs: Many provide EBRT/IMRT and coordinated urology–radiation care; ask about experience and outcomes for your risk group.
  • Find specialists: Locate a urologist via the Urology Care Foundation and a radiation oncologist via RTAnswers.

Side effects and recovery: what to expect

  • Urinary function: Temporary irritation is common after radiation; incontinence risk is higher after surgery but often improves with time and pelvic floor therapy.
  • Sexual health: Erections may decline after any local therapy; nerve-sparing surgery, dose planning, medications, devices, and rehab can help.
  • Bowel function: Radiation can cause short-term urgency or looseness; modern techniques minimize risk of lasting problems.
  • Hormone therapy effects: Hot flashes, fatigue, weight/muscle changes, and metabolic effects are possible; exercise and diet strategies mitigate many issues. Learn more about hormone therapy.

Practical tips for a smoother journey

  • Track your numbers: Keep a simple log of PSA, MRI/biopsy results, and treatment dates.
  • Optimize fitness: Quit smoking, walk daily, and do light strength training—these improve surgical and radiation outcomes.
  • Get support: Peer groups can ease decision stress; start with ZERO Prostate Cancer’s support resources.
  • Plan for costs: Ask about prior authorizations and financial counseling; see assistance options from CancerCare.

Questions to ask your care team

  • What is my risk group and stage, and what does that mean for cure rates?
  • What are my best options, and how do their side effects and recovery compare?
  • How many of these procedures have you done, and what are your outcomes?
  • Should I get additional imaging or genetic testing?
  • Am I eligible for a clinical trial?

The bottom line

Most men with localized prostate cancer have multiple effective options, and 5‑year survival for localized disease is excellent. With a clear understanding of the major treatments—active surveillance, surgery, EBRT, brachytherapy, and systemic therapies—you can choose a plan that fits your risk, health, and life priorities. Use the trusted resources above, seek multidisciplinary input, and take the time you need to decide with confidence.